$HCIL
Hongchang International Co., Ltd

2023 Q4 Form 10-Q Financial Statement

#000121390023086293 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue $51.40K $49.99K
YoY Change 176.49%
Cost Of Revenue $62.96K $17.76K
YoY Change 184.16%
Gross Profit -$11.56K $32.23K
YoY Change 172.44%
Gross Profit Margin -22.49% 64.47%
Selling, General & Admin $153.5K
YoY Change 353.05%
% of Gross Profit 476.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $137.2K $153.5K
YoY Change 8949.67% 353.19%
Operating Profit -$148.8K -$121.3K
YoY Change 9712.07% 450.16%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.00 $110.00
YoY Change -466.67%
Pretax Income -$140.7K -$121.2K
YoY Change 9178.83% 448.91%
Income Tax $3.826K $0.00
% Of Pretax Income
Net Earnings -$144.5K -$121.2K
YoY Change 9431.2% 448.91%
Net Earnings / Revenue -281.13% -242.45%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 518.8M shares 103.2M shares
Diluted Shares Outstanding 450.0M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.43K
YoY Change
Cash & Equivalents $895.7K $863.1K $11.43K
Short-Term Investments
Other Short-Term Assets $1.142M $849.3K $3.130K
YoY Change 36398.69% 27838.42%
Inventory $13.71K $25.45K
Prepaid Expenses $23.32K
Receivables $742.9K $14.00
Other Receivables $1.107M $996.1K $17.85K
Total Short-Term Assets $3.961M $2.792M $32.40K
YoY Change 12123.0% 9606.8% -13.3%
LONG-TERM ASSETS
Property, Plant & Equipment $3.193K $0.00
YoY Change
Goodwill
YoY Change
Intangibles $3.213K $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $706.9K $1.789M
YoY Change
Total Long-Term Assets $46.25M $44.49M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $3.961M $2.792M $32.40K
Total Long-Term Assets $46.25M $44.49M
Total Assets $50.22M $47.28M $32.40K
YoY Change 154867.19% 164299.76% -65.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $38.52K $16.15K
YoY Change 144.93% -6.95%
Accrued Expenses $385.8K $75.54K $285.1K
YoY Change 35.33% -76.93% 0.43%
Deferred Revenue $434.9K
YoY Change -7.82%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.055M $8.023M $2.005M
YoY Change -47.37% 335.65% 5.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $8.672M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.055M $8.023M $2.005M
Total Long-Term Liabilities $8.672M
Total Liabilities $9.728M $8.023M $2.005M
YoY Change 385.17% 335.65% 5.34%
SHAREHOLDERS EQUITY
Retained Earnings -$812.5K -$826.2K -$19.89M
YoY Change -95.91% 1.35%
Common Stock $518.8K $518.8K $1.032M
YoY Change -49.75% -49.75% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.49M $39.26M -$1.757M
YoY Change
Total Liabilities & Shareholders Equity $50.22M $47.28M $32.40K
YoY Change 154867.19% 164299.76% -65.36%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income -$144.5K -$121.2K
YoY Change 9431.2% 448.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$187.9K
YoY Change 676.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 192.4K
YoY Change 344.01%
NET CHANGE
Cash From Operating Activities -187.9K
Cash From Investing Activities 0.000
Cash From Financing Activities 192.4K
Net Change In Cash 4.450K
YoY Change -76.73%
FREE CASH FLOW
Cash From Operating Activities -$187.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
415582375 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
427054485 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-26731
dei Entity Registrant Name
EntityRegistrantName
HEYU BIOLOGICAL TECHNOLOGY CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0627910
dei Entity Address Address Line1
EntityAddressAddressLine1
Block 19
dei Entity Address Address Line2
EntityAddressAddressLine2
Hongchang Food Co., Ltd., Yuanhong Investment Zone
dei Entity Address Address Line3
EntityAddressAddressLine3
Donggao Village
dei Entity Address City Or Town
EntityAddressCityOrTown
Fuzhou City
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
350300
dei Entity Address Country
EntityAddressCountry
CN
dei City Area Code
CityAreaCode
(86)
dei Local Phone Number
LocalPhoneNumber
180 5901 6050
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
518831367 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3141 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
863119 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
25448 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
996098 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
18989 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
849328 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
83015 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2791579 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
26837950 usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
38674338 usd
CY2022Q4 hybt Land Use Right Net Non Current
LandUseRightNetNonCurrent
4316604 usd
CY2023Q3 hybt Land Use Right Net Non Current
LandUseRightNetNonCurrent
4024966 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1788843 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
31154554 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
44488147 usd
CY2022Q4 us-gaap Assets
Assets
31237569 usd
CY2023Q3 us-gaap Assets
Assets
47279726 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25255091 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
38522 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3553 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75540 usd
CY2023Q3 us-gaap Customer Advances Current
CustomerAdvancesCurrent
10517 usd
CY2023Q3 hybt Deferred Subsidies Current
DeferredSubsidiesCurrent
1930722 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
31656222 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8022932 usd
CY2022Q4 us-gaap Liabilities
Liabilities
31656222 usd
CY2023Q3 us-gaap Liabilities
Liabilities
8022932 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
415582375 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
415582375 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
518831367 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
518831367 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
415582 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
518831 usd
CY2022Q4 hybt Subscription Receivable
SubscriptionReceivable
415582 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39905228 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-433745 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-826180 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15092 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-341085 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-418653 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39256794 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31237569 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47279726 usd
CY2023Q3 us-gaap Revenues
Revenues
51397 usd
us-gaap Revenues
Revenues
78204 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
62955 usd
us-gaap Cost Of Revenue
CostOfRevenue
104430 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-11558 usd
us-gaap Gross Profit
GrossProfit
-26226 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1399 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1399 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
75684 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
137193 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
150939 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
381579 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
77083 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
137193 usd
us-gaap Operating Expenses
OperatingExpenses
152338 usd
us-gaap Operating Expenses
OperatingExpenses
381579 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-77083 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-148751 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-152338 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-407805 usd
CY2022Q3 us-gaap Interest Income Operating
InterestIncomeOperating
2 usd
CY2023Q3 us-gaap Interest Income Operating
InterestIncomeOperating
453 usd
us-gaap Interest Income Operating
InterestIncomeOperating
5 usd
us-gaap Interest Income Operating
InterestIncomeOperating
924 usd
CY2023Q3 us-gaap Other Income
OtherIncome
7630 usd
us-gaap Other Income
OtherIncome
18309 usd
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-12 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-37 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77081 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-140667 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-152345 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-388609 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3826 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3826 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-77081 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-144493 usd
us-gaap Net Income Loss
NetIncomeLoss
-152345 usd
us-gaap Net Income Loss
NetIncomeLoss
-392435 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-77081 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-144493 usd
us-gaap Net Income Loss
NetIncomeLoss
-152345 usd
us-gaap Net Income Loss
NetIncomeLoss
-392435 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-31926 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-463178 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
25576 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-356177 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-109007 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-607671 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-126769 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-748612 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00019
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00032
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00037
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00092
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
415582375 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
449998706 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
415582375 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
427054485 shares
us-gaap Net Income Loss
NetIncomeLoss
-152345 usd
us-gaap Net Income Loss
NetIncomeLoss
-392435 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62771 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
59602 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
18026 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26405 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
18358 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
862632 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1425 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2821 usd
hybt Increase Decrease Advance From Customer
IncreaseDecreaseAdvanceFromCustomer
-10913 usd
hybt Increase Decrease Deferred Subsidies
IncreaseDecreaseDeferredSubsidies
2003319 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-109357 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
777143 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
954232 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40391648 usd
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
1015527 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-954232 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41407175 usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
42384737 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2660425 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1062404 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1792987 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1062404 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41517299 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-194 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-27289 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1379 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
859978 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2645 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3141 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1266 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
863119 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-193756 usd
us-gaap Net Income Loss
NetIncomeLoss
-152345 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
25576 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-320525 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-418653 usd
us-gaap Net Income Loss
NetIncomeLoss
-392435 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-356177 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
41241108 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-817049 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
39256794 usd
CY2023Q3 hybt Share Capital Issued And Outstanding
ShareCapitalIssuedAndOutstanding
518831367 shares
CY2023Q3 us-gaap Common Unit Issued
CommonUnitIssued
415582375 shares
CY2023Q3 hybt Percentage Of Share Capital
PercentageOfShareCapital
0.801 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>(c) Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related disclosures of contingent assets and liabilities at the balance sheet date, and the reported revenue and expenses during the reported period in the consolidated financial statements and accompanying notes. Significant accounting estimates reflected in the Group’s consolidated financial statements mainly include, but are not limited to, standalone selling price of each distinct performance obligation in revenue recognition, estimated useful life of land use right, assessment for impairment of long-lived assets, valuation of deferred tax assets and current expected credit loss of receivables. Actual results could differ from those estimates.</p>
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7.2952 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6.8983 usd
CY2023Q3 hybt Land Use Right Net Non Current
LandUseRightNetNonCurrent
4024966 usd
CY2022Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
18989 usd
CY2023Q3 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
848711 usd
CY2023Q3 us-gaap Supplies
Supplies
617 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
18989 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
849328 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
26837950 usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
38674338 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
26837950 usd
CY2023Q3 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
38674338 usd
CY2023Q3 us-gaap Area Of Land
AreaOfLand
130000 sqm
CY2022Q4 us-gaap Land
Land
4504282 usd
CY2023Q3 us-gaap Land
Land
4259224 usd
CY2022Q4 us-gaap Accumulated Amortization Of Other Deferred Costs
AccumulatedAmortizationOfOtherDeferredCosts
187678 usd
CY2023Q3 us-gaap Accumulated Amortization Of Other Deferred Costs
AccumulatedAmortizationOfOtherDeferredCosts
234257 usd
CY2022Q4 hybt Land Use Right Net Non Current
LandUseRightNetNonCurrent
4316604 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62771 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
59602 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2464 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71791 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1089 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3749 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
3553 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
75540 usd
hybt Contribution From Shareholder
ContributionFromShareholder
41241109 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-817049 usd
CY2023Q3 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
40424060 usd
CY2023Q1 us-gaap Shares Outstanding
SharesOutstanding
100 shares
CY2023Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
1 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
100 shares
us-gaap Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions
SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions
100 shares
CY2023Q2 us-gaap Other Additional Capital
OtherAdditionalCapital
41241109 usd
CY2023Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
100 shares
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
415582375 shares
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2022 us-gaap Assets Average Outstanding
AssetsAverageOutstanding
46517560 usd
us-gaap Assets Average Outstanding
AssetsAverageOutstanding
23114913 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2022Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
usd
CY2022Q4 hybt Deferred Subsidies Current
DeferredSubsidiesCurrent
usd
CY2023Q3 hybt Subscription Receivable
SubscriptionReceivable
usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022Q3 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
usd
CY2022Q3 us-gaap Other Income
OtherIncome
usd
us-gaap Other Income
OtherIncome
usd
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00019
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00032
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00037
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00092
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
415582375 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
449998706 shares
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
hybt Increase Decrease Advance From Customer
IncreaseDecreaseAdvanceFromCustomer
usd
hybt Increase Decrease Deferred Subsidies
IncreaseDecreaseDeferredSubsidies
usd
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
usd
us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
usd
CY2022Q1 hybt Beginning Balance As Of Common Stock Other Value Outstanding
BeginningBalanceAsOfCommonStockOtherValueOutstanding
usd
hybt Ending Balance As Of Common Stock Other Value Outstanding
EndingBalanceAsOfCommonStockOtherValueOutstanding
usd
CY2022Q4 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
usd
us-gaap Recapitalization Costs
RecapitalizationCosts
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001086303

Files In Submission

Name View Source Status
0001213900-23-086293-index-headers.html Edgar Link pending
0001213900-23-086293-index.html Edgar Link pending
0001213900-23-086293.txt Edgar Link pending
0001213900-23-086293-xbrl.zip Edgar Link pending
f10q0923ex31-1_heyubio.htm Edgar Link pending
f10q0923ex31-2_heyubio.htm Edgar Link pending
f10q0923ex32-1_heyubio.htm Edgar Link pending
f10q0923ex32-2_heyubio.htm Edgar Link pending
f10q0923_heyubiolog.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hybt-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
hybt-20230930_cal.xml Edgar Link unprocessable
hybt-20230930_def.xml Edgar Link unprocessable
hybt-20230930_lab.xml Edgar Link unprocessable
hybt-20230930_pre.xml Edgar Link unprocessable
f10q0923_heyubiolog_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable